Groupe la Francaise’s Pulmonx LUNG Stock Holding History

Groupe la Francaise’s Portfolio LUNG Stock Details LUNG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-2,500	Closed	-$3.51K	–	635
2025 Q3	$3.51K	Buy	+2,500	New	+$5.23K	﹤0.01%	669

Other funds holding LUNG

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

ECM

ExodusPoint Capital Management New York $12.6B AUM 30.13% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Groupe la Francaise's LUNG Position: Q4 2025 in Review

Groupe la Francaise sold out of Pulmonx (LUNG) in Q4 2025, closing a stake of 2,500 shares — an estimated $3.51K sold.

Groupe la Francaise first reported a position in LUNG in Q3 2025 and held it in 1 quarter. The position peaked at $3.51K in Q3 2025. 112 funds tracked by Wall St. Rank hold LUNG as of Q4 2025.

Groupe la Francaise reported no remaining Pulmonx position as of Q4 2025 after selling out during the quarter.
Groupe la Francaise sold 2,500 Pulmonx shares in Q4 2025, an estimated $3.51K.
Groupe la Francaise first reported a position in Pulmonx in Q3 2025 and held it in 1 quarter.
Groupe la Francaise's Pulmonx position peaked at $3.51K in Q3 2025.
112 funds tracked by Wall St. Rank held Pulmonx as of Q4 2025.

Based on Groupe la Francaise's 13F filing for Q4 2025, filed 12 Feb 2026.